"There is not a quick fix. Our goal is to continue to be the brand solution of choice for our consumers, and this will require us to become even better at design, engineering, and marketing."
— Scott Azel
03Detailed Report
HELE
Company HELE
Period
Q2 2026
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedJun 23, 2026
Swipe to view all report sections
Executive Summary
Helen of Troy (HELE) delivered a challenging QQ2 2026, with consolidated net sales of $431.8 million and a GAAP operating loss of $315.7 million, driven by a $326.4 million non-cash impairment charge and tariff-related headwinds. The quarter reflected a broad margin compression: gross margin at 44.2% and an adjusted operating margin of 6.2%, down notably from the prior year. The impairment and tariff dynamics weighed heavily on profitability, while Olive & June contributed $33.4 million of revenue and is advancing as a meaningful growth vector within the portfolio. Management underscored a deliberate renewal plan, prioritizing consumer-centric innovation, streamlined execution, and capital discipline to restore higher-margin growth and cash generation over time.
Management presented a multi-quarter pathway to stabilization and growth anchored by four pillars: (1) accelerate execution by simplifying the operating model and placing brands closer to the consumer; (2) refocus on core brands with high growth potential and improve design, engineering, and marketing to deliver best-in-class products; (3) strengthen balance sheet and free cash flow to support debt reduction and disciplined capital allocation; and (4) continue tariff mitigation through diversification, pricing actions, and cost reductions. While near-term volatility remains, the company communicates a belief that transitory tariff and mix effects will moderate as pricing actions take hold and supply chains diversify. The full-year guidance contemplates continued headwinds but expects improvement in the second half of fiscal 2026 and into fiscal 2027 as the company cycles out tariff drag and leverages new product momentum. Investors should monitor (i) tariff tailwinds/offsets and price realization, (ii) Olive & June contribution to profitability, (iii) progress on Project Pegasus cost initiatives, and (iv) the pace of debt reduction toward a target leverage around 2x.
Key Performance Indicators
Revenue
Decreasing
431.78M
QoQ: 16.18% | YoY: -8.95%
Gross Profit
Decreasing
190.68M
44.16% margin
QoQ: 8.95% | YoY: -11.75%
Operating Income
Decreasing
-315.72M
QoQ: 22.44% | YoY: -1 005.88%
Net Income
Decreasing
-308.64M
QoQ: 31.52% | YoY: -1 914.05%
EPS
Decreasing
-13.44
QoQ: 31.60% | YoY: -1 892.00%
Revenue Trend
Margin Analysis
Financial Highlights
Financial snapshot and key trend highlights:
- Revenue: QQ2 2026 net sales of $431.8 million, down 8.9% year-over-year and up 16.2% quarter-over-quarter (Q2’26 vs Q1’26 of $371.7 million). YoY decline driven by tariff headwinds, category softness, and international dynamics.
- Gross profit and margin: Gross profit of $190.7 million; gross margin 44.16% (down ~140 bps YoY, with tariffs contributing roughly 200 bps of gross margin pressure). Positive contributions from Olive & June partially offset the headwinds.
- Operating profitability: GAAP operating loss of $315.7 million; adjusted operating margin 6.2%, down ~360 bps YoY as tariffs and higher promotional spending compressed profitability. Olive & June accruals provided partial offset but were not sufficient to offset impairment and tariff effects.
- Impairment: Non-cash asset impairment charge of $326.4 million weighed heavily on GAAP results, reflecting the sustained stock-price decline and the non-cash nature of the write-down.
- Net income and EPS: Net income of -$308.6 million; diluted EPS -$13.44 (GAAP). Non-GAAP adjusted EPS was $0.59, down from $1.21 in the prior-year period.
- Cash flow and liquidity: Operating cash flow was negative at -$10.5 million for the quarter; free cash flow $2.9 million; ending cash of $22.37 million. Total debt stood at $893.2 million; net debt approximately $910.3 million; net leverage about 3.5x. Revolver availability was $578.6 million with covenant headroom under current terms, though management signaled potential covenant relief discussions.
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
431.78M
-8.95%
16.18%
Gross Profit
190.68M
-11.75%
8.95%
Operating Income
-315.72M
-1 005.88%
22.44%
Net Income
-308.64M
-1 914.05%
31.52%
EPS
-13.44
-1 892.00%
31.60%
Key Financial Ratios
Gross Profit Margin
Good
44.20%
Gross profit margin is healthy and competitive within industry standards
Operating Profit Margin
Weak
-0.73%
Operating margin is below industry norms, profitability concerns
Net Profit Margin
Weak
-0.72%
Net profit margin is below industry norms, profitability concerns
Return on Assets
Weak
-0.13%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
-0.33%
Return on equity suggests inefficient capital allocation
Current Ratio
Healthy
1.71
Current ratio shows adequate liquidity to meet short-term obligations
Debt to Equity
High Risk
1.01
Debt-to-equity indicates high leverage and elevated financial risk
P/E Ratio
Negative
-0.46x
Negative earnings make P/E ratio not meaningful
Price to Book
Undervalued
0.61x
Trading below book value, potential value opportunity or distressed
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.
Helen of Troy Limited (HELE) QQ3 2026 Results Analysis — Stabilizing Brand Momentum in Consumer Defensive, Tariff Headwinds, and Path to Growth into...
The Clorox Company (CLX) QQ2 2026 Results — Resilient topline, ERP disruption largely resolved, and an innovation-led back-half ramp with Gojo integ...